Molecular Classification of Triple-Negative Breast Cancer

  title={Molecular Classification of Triple-Negative Breast Cancer},
  author={Sung Gwe Ahn and Seung Jun Kim and Cheungyeul Kim and Joon Jeong},
  booktitle={Journal of breast cancer},
Tumor heterogeneity of triple-negative breast cancer (TNBC) has been the main barrier in conquering breast cancer. To dissect the molecular diversity of TNBC and discover therapeutic targets for TNBC, the molecular classification of TNBC is a prioritized issue in research area. Accordingly, recent studies have been successful in classifying TNBC into several distinct subtypes with specific biologic pathways. Despite the different methodologies used and varied number of final subtypes, these… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 13 extracted citations

ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1

Journal of experimental & clinical cancer research : CR • 2017
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 32 references

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2015
View 7 Excerpts
Highly Influenced

Results from a phase 2 study of enzalutamide (ENZA), an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)

TA Traina, K Miller, +3 authors A Awada
J Clin Oncol 2015;33(15 • 2015
View 6 Excerpts
Highly Influenced

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer

Cancer informatics • 2012
View 3 Excerpts
Highly Influenced

The TNT trail : a randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA 1 / 2 breast cancer

J O’Shaughnessy, L Schwartzberg, +3 authors M Neubauer
Cancer Res • 2015

Similar Papers

Loading similar papers…